MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-HR-18-0003623
Antex Pharma Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹98.92 Cr
▲ 23% YoY
Net profit · FY 2024
₹62.06 Lakh
Net margin 0.6%
EBITDA · FY 2024
₹1.12 Cr
EBITDA margin 1.1%
Authorised capital
₹70 Lakh
Registered with MCA
Paid-up capital
₹70 Lakh
Issued & subscribed
Open charges
₹13.5 Cr
Satisfied ₹13.2 Cr
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings
About Antex Pharma Private Limited
Data last updated:
Antex Pharma Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2009PTC188276. Its GSTIN is 06AAHCA8532F1ZS (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹70 Lakh. It is led by directors Rajesh Kumar Hariharprasad Tiwari and Amardeep Bansal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 423 Main Bawana Road Shahbad Daulatpur, Delhi, India – 110042.
As per the financials filed for FY 2024, the company reported a revenue of ₹98.92 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹62.06 Lakh (net margin 0.6%) and EBITDA of ₹1.12 Cr (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 1% over five years.
The company is associated with 1 brand: Antex Pharma. As per MCA filings, the company has open charges of ₹13.5 Cr and satisfied charges of ₹13.2 Cr on record. Court records list 224 cases involving the company, including 203 filed by the company and 21 filed against it; 116 cases are pending.
Antex Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-18-0003623). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website antexpharma.com.
Company details
CIN U24100DL2009PTC188276
Registration Number 188276
Incorporation Date 06 March 2009
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HR-18-0003623
Recognitions & Rankings of Antex Pharma
Contact details
Antex Pharma Private Limited's registered office is in Delhi, Delhi. Its website is antexpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address423 Main Bawana Road Shahbad Daulatpur, Delhi, India – 110042
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Antex Pharma Private Limited, buy the company report.
Comprehensive company report
Antex Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Antex Pharma operates one associated brand: Antex Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Marketing and distribution of pharmaceutical products and health supplements in India. | antexpharma.com |
Business activity
The main business activity of Antex Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Antex Pharma Private Limited, buy the company report.
Financials of Antex Pharma Private Limited
FY 2024 filings availableAntex Pharma Private Limited reported revenue of ₹98.92 Cr (up 23% YoY) for FY 2024.
Revenue · FY 2024
₹98.92 Cr ▲ 23%
Net profit · FY 2024
₹62.06 Lakh margin 0.6%
EBITDA · FY 2024
₹1.12 Cr margin 1.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 7%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 53%
3 years · compounded
▼ 7%
5 years · compounded
▼ 2%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 23% growth in the latest year. EBITDA fell 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.12 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹62.06 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Antex Pharma Private Limited, buy the company report.
Board of directors of Antex Pharma Private Limited
Antex Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Hariharprasad Tiwari | Director | 12 Dec 2019 | 6 Years 10 Months | Current |
| Amardeep Bansal Also directs: Acacia Pax LLP, Shell Agro Infrastructure Private Limited, Alexza Labs Private Limited and 1 more | Director | 06 Mar 2009 | 17 Years 7 Months | Current |
Peer comparison
Antex Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amtrax (India) Life Sciences Private Limited | ₹100.75 Cr (FY 2025) | -8.0% | Mumbai, Maharashtra, India | |||
| Euro Lifecare Private Limited | ₹100.42 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Arham Drugs and Chemicals Private Limited | ₹100.31 Cr (FY 2024) | 119.0% | Mumbai, Maharashtra, India | |||
| Antex Pharma Private Limitedthis company | ₹98.92 Cr (FY 2024) | ₹62.06 Lakh | 0.6% | 23.0% | Delhi, India | |
| Visa Pharmaceuticals Private Limited | ₹98.08 Cr (FY 2016) | 34.0% | Kolkata, West Bengal, India | |||
| Inspira Bio-Pharm Private Limited | ₹97.29 Cr (FY 2025) | -17.0% | Mumbai, Maharashtra, India | |||
| Vea Impex (I) Private Limited | ₹96.93 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Antex Pharma Private Limited, buy the company report.
Auditor
Antex Pharma Private Limited is audited by ANKIT SK JAIN & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANKIT SK JAIN & CO. | FY 2023 | 032983N |
Shareholding
The shareholding of Antex Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Antex Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹13.5 Cr
Satisfied charges
₹13.2 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Oct 2025 | 101179563 | Hdfc Bank Limited | ₹8 Cr | Open | |
| 18 Oct 2023 | 100803158 | Yes Bank Limited | ₹5 Cr | Open | |
| 24 Oct 2020 | 100416018 | Hdfc Bank Limited | ₹50 Lakh | Open | |
| 25 Nov 2024 | 101011816 | Uco Bank | ₹4.95 Cr | Satisfied | |
| 02 Jul 2015 | 10592193 | Hdfc Bank Limited | ₹6 Cr | Satisfied |
To see the full charge records of Antex Pharma Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Antex Pharma Private Limited has 224 court cases on record: 203 filed by Antex Pharma, 21 filed against it. 116 cases are pending and 108 are disposed.
Total cases
224
Filed by the company
203
Filed against the company
21
Pending
116
Disposed
108
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 189 | 9 | 109 |
| High courts | 34 | 11 | 7 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 224)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North, Delhi | Civil suit | Filed by the company against Yes Bank Ltd | Pending |
| District court, North West, Delhi | Civil suit | Filed against the company by Gnosis Pharmaceuticals Pvt Ltd | Disposed |
| High Court, TAMIL NADU | Original application | Filed against the company by Apex Laboratories Pvt Ltd Sathish Kumar, Mehavarshni,Sridharshini S. | Disposed |
| High Court, TAMIL NADU | Appeal | Filed against the company by Apex Laboratories Pvt Ltd M/S.R.Sathish Kumar, Sridharshini S.,Mehavarshni | Disposed |
| High Court, TAMIL NADU | Court case (C.S(COMM DIV)) | Filed against the company by M/S. Apex Laboratories Pvt Ltd | Disposed |
To see the full case history of Antex Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Antex Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Antex Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCA8532F1ZS | Haryana | Active | 17 Jan 2019 |
To see the full GST registrations and return filing status of Antex Pharma Private Limited, buy the company report.
Recent activity
Antex Pharma Private Limited has 8 board changes on record since 2009: 2 appointments and 6 cessations. The latest: Rajesh Kumar Hariharprasad Tiwari ceased to be Additional Director on 09 May 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 800.00 Lakh registered on 25 Oct 2025 with Charge ID 101179563 was modified on 19 Nov 2025.
Charges
A charge registered on 25 Nov 2024 via Charge ID 101011816 with Uco Bank was fully satisfied on 30 Oct 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 800.00 Lakh with Charge ID 101179563 was registered on 25 Oct 2025.
Ceased
Rajesh Kumar Hariharprasad Tiwari ceased to be Additional Director.
Charges
A charge with Uco Bank amounted to Rs. 495.00 Lakh with Charge ID 101011816 was registered on 25 Nov 2024.
AGM
Antex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Antex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Yes Bank Limited amounted to Rs. 500.00 Lakh with Charge ID 100803158 was registered on 18 Oct 2023.
Charges
A charge registered on 02 Jul 2015 via Charge ID 10592193 with Hdfc Bank Limited was fully satisfied on 18 Aug 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 599.92 Lakh registered on 02 Jul 2015 with Charge ID 10592193 was modified on 21 Jan 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 100416018 was registered on 24 Oct 2020.
Appointed
Rajesh Kumar Hariharprasad Tiwari was appointed as Director.
13 earlier events are in the company report.
Frequently asked questions
Antex Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 March 2009 (17+ years old) and is registered under CIN U24100DL2009PTC188276.
Antex Pharma has 2 current directors:
- Rajesh Kumar Hariharprasad Tiwari - Director
- Amardeep Bansal - Director
The latest financial statements of Antex Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Antex Pharma is 06AAHCA8532F1ZS, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Antex Pharma is U24100DL2009PTC188276. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Antex Pharma has 224 court cases on record: 203 filed by the company and 21 filed against it. 116 are pending. Most are in the district courts.
Antex Pharma was incorporated on 06 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Antex Pharma by revenue are Amtrax (India) Life Sciences Private Limited, Euro Lifecare Private Limited, Arham Drugs and Chemicals Private Limited, Visa Pharmaceuticals Private Limited, Inspira Bio-Pharm Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rajesh Kumar Hariharprasad Tiwari ceased to be Additional Director on 09 May 2025. Rajesh Kumar Hariharprasad Tiwari was appointed as Director on 12 Dec 2019. Sunny Mittal ceased to be Additional Director on 12 Dec 2019. Antex Pharma has 8 board changes on record in total.
Yes, Antex Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-18-0003623).
Antex Pharma can be reached through the website antexpharma.com. Its registered office is in Delhi, India.